Fingerprint
Dive into the research topics of 'The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
Lynne M. Bird, Cesar Ochoa-Lubinoff, Wen Hann Tan, Gali Heimer, Raun D. Melmed, Amit Rakhit, Jeannie Visootsak, Matthew J. During, Christina Holcroft, Rebecca D. Burdine, Alexander Kolevzon*, Ronald L. Thibert
*Corresponding author for this work
- University of California at San Diego
- Rady Children's Hospital
- Rush University
- Harvard University
- Sheba Medical Center at Tel Hashomer
- Southwest Autism Research and Resource Center
- Ovid Therapeutics Inc
- Neurogene Inc.
- LLC
- Princeton University
- Icahn School of Medicine at Mount Sinai
- Massachusetts General Hospital
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations